COVID-19, First wave, Obstetric outcome, Second wave
Citation Information :
Choudhary N, Munda G, Anupma A, Anand U, Agarwal S, Khera S. Comparison of Obstetric Outcomes in First and Second COVID-19 Waves: Analysis from a COVID-19-dedicated Tertiary Care Hospital. J South Asian Feder Obs Gynae 2023; 15 (2):161-164.
Introduction: The physiological changes in the respiratory and cardiovascular systems in the immunosuppressed state of pregnancy may exacerbate clinical features and deteriorate outcomes due to COVID-19 infection. We aimed to compare the maternal and neonatal adverse effects in the first and second COVID-19 waves.
Methodology: This study was a prospective cohort study conducted in a tertiary care COVID-19-dedicated hospital. In total, 104 (group A) and 96 (group B) COVID-19-positive pregnant women admitted during the first and second waves, respectively, were included in the study. Data on baseline variables, associated comorbidities, clinical presentations, management strategies, and neonatal and maternal outcomes were collected and compared using parametric and nonparametric tests and analyzed.
Results: Around 2.08% in group A and 6.72% in group B of COVID-19-infected pregnant women, respectively, had moderate-to-severe disease and required intensive care unit stay. Almost 1.04% in group A and 3.84% in group B had maternal mortality, 13.4% and 19.8% babies of groups A and B required admission in neonatal intensive care units, and 8.6% and 7.3% of newborns in groups A and B had COVID-19-positive reports by reverse transcriptase polymerase chain reaction (RT-PCR) at birth, respectively. Of them, 2.1% newborns in group B had RT-PCR positive on day 7 of life and beyond, whereas none had positive RT-PCR reports on 7 days and beyond in group A.
Conclusion: Dreadful maternal outcomes like requirement of ICU and mechanical ventilator and persistence of neonatal infections were higher during the second wave.
Zhu N, Zhang D, Wang W, et al. Brief report: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727–733. DOI: 10.1056/NEJMoa2001017.
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91(1):157–160. DOI: 10.23750/abm.v91i1.9397.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648.
Weetman AP. Immunity, thyroid function and pregnancy: Molecular mechanisms. Nat Rev Endocrinol 2010;6(6):311–318. DOI: 10.1038/nrendo.2010.46.
Rasmussen SA, Smulian JC, Lednicky JA, et al. Coronavirus disease 2019 (COVID-19) and pregnancy: What obstetricians need to know. Am J Obstet Gynecol 2020;222(5):415–426. DOI: 10.1016/j.ajog.2020.02.017.
Jilani TN, Jamil RT, Siddiqui AH, et al. H1N1 Influenza (Nursing) 2022:1–9. Available from: https://pubmed.ncbi.nlm.nih.gov/33760493/
Rasmussen SA, Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregnancy: Responding to a rapidly evolving situation. Obstet Gynecol 2020;135(5):999–1002. DOI: 10.1097/AOG.0000000000003873.
Chmielewska B, Barratt I, Townsend R, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: A systematic review and meta-analysis. Lancet Glob Heal 2021;9(6):e759–e772. DOI: 10.1016/S2214-109X(21)00079-6.
DeSisto CL, Wallace B, Simeone RM, et al. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization — United States, March 2020–September 2021. MMWR Morb Mortal Wkly Rep 2021;70(47):1640–1645.
Sarkar A, Chakrabarti AK, Dutta S. COVID-19 infection in India: A comparative analysis of the second wave with the first wave. Pathogens 2021;10(9):1222. DOI: 10.3390/pathogens10091222.
Singh V, Choudhary A, Datta MR, et al. Maternal and neonatal outcomes of COVID-19 in pregnancy: A single-centre observational study. Cureus 2021;13(2):e13184. DOI: 10.7759/cureus.13184.
Dave A, Avashia S, Jhavar D, et al. Characteristics and outcomes of COVID-19 (SARS-CoV-2) positive pregnant women admitted to a dedicated COVID hospital in Central India: A single-center observational study. J South Asian Feder Obst Gynaecol 2021;13(4):245–250. DOI: 10.5005/jp-journals-10006-1919.
Asrani P, Eapen MS, Hassan MI, et al. Implications of the second wave of COVID-19 in India. Lancet Respir Med 2021;9(9):e93–e94. DOI: 10.1016/S2213-2600(21)00312-X.
Mahajan NN, Pophalkar M, Patil S, et al. Pregnancy outcomes and maternal complications during the second wave of coronavirus disease 2019 (COVID-19) in India. Obstet Gynecol 2021;138(4):660–662. DOI: 10.1097/AOG.0000000000004529.
Chaudhary D, Chauhan M, Gupta D, et al. A comparative review of maternal and neonatal outcome among pregnant women with COVID-19 in first and second wave in a tertiary care centre of South Rajasthan. Int J Reprod Contraception, Obstet 2021;10(12):4471–4477. DOI: 10.18203/2320-1770.ijrcog20214644.
Kadiwar S, Smith JJ, Ledot S, et al. Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet 2021;397(10284):1539–1540. DOI: 10.1016/S0140-6736(21)00716-9.
Woodworth KR, Olsen EO, Neelam V, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020. MMWR Morb Mortal Wkly Rep 2020;69(44):1635–1640. DOI: 10.15585/mmwr.mm6944e2.
Kotlyar AM, Grechukhina O, Chen A, et al. Vertical transmission of coronavirus disease 2019: A systematic review and meta-analysis. Am J Obstet Gynecol 2021;224(1):35–53.e3. DOI: 10.1016/j.ajog.2020.07.049.
Hosier H, Farhadian SF, Morotti RA, et al. SARS–CoV-2 infection of the placenta. J Clin Invest 2020;130(9):4947–4953. DOI: 10.1172/JCI139569.
Parpillewar M. Maternal and neonatal outcomes of pregnant women with COVID-19: A case–control study at a tertiary care center in India. J South Asian Feder Obst Gynae 2021;13(1):44–49.